Advertisement

Botulinum Toxin for Hyperhidrosis in the Axillary Area

  • Ada Regina Trindade de AlmeidaEmail author
  • Suelen Montagner
Living reference work entry

Latest version View entry history

Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)

Abstract

Axillary hyperhidrosis (AH) impacts social and occupational lives of lots of people in all continents, and its real incidence probably is underestimated. Botulinum toxin is a safe and effective treatment option for axillary hyperhidrosis. Although its pathophysiology is not very clear, with some controversial topics, so far the beneficial effect of neuromodulators in inhibiting localized sweating temporarily is well known.

Before the procedure, the correct identification of the affected area is mandatory. The objective is to enhance efficacy avoiding drug waste or leaving areas without treatment, because the hyperhidrotic location does not always match the hairy axillary region.

Handling this medication, including dilution and injection techniques, depends on medical experience and may have some variations, including methods to make the procedure as painless as possible. Evidence supports a Level A recommendation for BoNT-A for axillary hyperhidrosis.

Keywords

Axillary hyperhidrosis Excessive underarm sweating Botox Botulinum toxin Neuromodulators 

References

  1. An JS, Hyun Won C, Si Han J, Park HS, Seo KK. Comparison of onabotulinumtoxinA and rimabotulinumtoxinB for the treatment of axillary hyperhidrosis. Dermatol Surg. 2015;41(8):960–7.PubMedCrossRefGoogle Scholar
  2. Atkins JL, Butler PEM. Hyperhidrosis: a review of current management. Plast Reconstr Surg. 2002;110:222–8.PubMedCrossRefGoogle Scholar
  3. Bahmer F, Sachse M. Hyperhidrosis area and severity index (letter). Dermatol Surg. 2008;34:1744–5.PubMedGoogle Scholar
  4. Baumann L, et al. Pilot study of the safety and efficacy of MyoblocTM (botulinum toxin type B) for treatment of axillary hyperhidrosis. Int J Dermatol. 2005;44:418–24.PubMedCrossRefGoogle Scholar
  5. Bechara F. Do we have apocrine sweat glands? Int J Cosmet Sci. 2008;30:67–8.PubMedCrossRefGoogle Scholar
  6. Bovell DL, Clunes MT, Elder HY, Milsom J, Mc Ewan Jenkinson D. Ultrastructure of the hyperhidrotic eccrine sweat gland. Br J Dermatol. 2001;145:298–301.PubMedCrossRefGoogle Scholar
  7. Bovell D, Corbett A, Holmes S, et al. The absence of apocrine glands in the human axilla has disease pathogenetic implications, including axillary hyperhidrosis. Br J Dermatol. 2007;156:1278–86.PubMedCrossRefGoogle Scholar
  8. Bovell DL, et al. The secretory clear cell of the eccrine sweat gland as the probable source of excess sweat production in hyperhidrosis. Exp Dermatol. 2011;20(12):1017–20.PubMedCrossRefGoogle Scholar
  9. Brehmer F, Lockmann A, Grönemeyer LL, Kretschmer L, Schön MP, Thoms KM. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients. J Dtsch Dermatol Ges. 2015;13(8):799–805.PubMedGoogle Scholar
  10. Burks RI. Povidone-iodine solution in wound treatment. Phys Ther. 1998;78(2):212–8.PubMedCrossRefGoogle Scholar
  11. Bushara KO, Park DM. Botulinum toxin and sweating (Letter). J Neurol Neurosurg Psychiatry. 1994;54(11):1437.CrossRefGoogle Scholar
  12. Carruthers A, Alastair J. You want to inject what? Dermatol Surg. 2015;41:S2–8.PubMedCrossRefGoogle Scholar
  13. Chow A, Wilder-Smith EP. Effect of transdermal botulinum toxin on sweat secretion in subjects with idiopathic palmar hyperhidrosis. Br J Dermatol. 2009;160(3):721–3.PubMedCrossRefGoogle Scholar
  14. Cohen JL, Cohen G, Solish N, et al. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy. Facial Plast Surg Clin North Am. 2007;15:17–30, v–vi.PubMedCrossRefGoogle Scholar
  15. De Campos JR, Kauffman P, Werebe Ede C, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76:886–91.PubMedCrossRefGoogle Scholar
  16. Doft MA, Kasten JL, Ascherman JA. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon’s experience with 53 consecutive patients. Aesthet Plast Surg. 2011;35:1079–86.CrossRefGoogle Scholar
  17. Dressler D. Comparing Botox and Xeomin for axillar hyperhidrosis. J Neural Transm. 2010;117:317–9.PubMedCrossRefGoogle Scholar
  18. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol. 2002;249(12):1729–32.PubMedCrossRefGoogle Scholar
  19. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.PubMedCrossRefGoogle Scholar
  20. Frasson E, Brigo F, Acler M, Didine G, Vicentini S, Bertolase L. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Arch Dermatol. 2011;147(1):122–3.PubMedCrossRefGoogle Scholar
  21. Glaser DA, Hebert AA, Pariser DM, Solish N. Primary focal hyperhidrosis: scope of the problem. Cutis. 2007;79(5):5–17.PubMedGoogle Scholar
  22. Glogau R. Hyperhidrosis and botulinum toxin A: patient selection and techniques. Clin Dermatol. 2004;22:45–52.PubMedCrossRefGoogle Scholar
  23. Glogau RG. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg. 2007;33(1):S76–80.PubMedCrossRefGoogle Scholar
  24. Glogau R, Blitzer A, Brandt F, Kane M, Monheit GD, Waugh JM. Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines. J Drugs Dermatol. 2012;11(1):38–45.Google Scholar
  25. Goodman G. Diffusion and short-term efficacy of botulinum toxin A after addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg. 2003;29:533–8.PubMedGoogle Scholar
  26. Grimalt R, Moreno-Arias GA, Ferrando J. Multi-Injection plate for botulinum toxin application in the treatment of axillary hyperhidrosis. Dermatol Surg. 2001;27:543–4.PubMedGoogle Scholar
  27. Grunfeld A, Murray CA, Solish N. Botulinum toxin for hyperhidrosis: a review. Am J Clin Dermatol. 2009;10(2):87–102.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Gülec AT. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study. J Eur Acad Dermatol Venereol. 2012;26:314–8.PubMedCrossRefGoogle Scholar
  29. Hamm H, Naumann MK, Kowalski JW, Kutt S, Kozma C, Teale C. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology. 2006;212:343–53.PubMedCrossRefGoogle Scholar
  30. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344(7):488–93.PubMedCrossRefGoogle Scholar
  31. Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LR. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51:274–86.PubMedCrossRefGoogle Scholar
  32. Hund M, Kinkelin I, Naumann M, et al. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol. 2002;138:539–41.PubMedCrossRefGoogle Scholar
  33. Jain S. A new multiple site marking grid for botulinum toxin application in the treatment of axillary hyperhidrosis. Br J Dermatol. 2006;154:375–91.CrossRefGoogle Scholar
  34. Kalner IJ. Same-patient prospective comparison of Botox versus Dysport for treatment of primary axillary hyperhidrosis and review of literature. J Drugs Dermatol. 2011;10(9):1013–5.Google Scholar
  35. Klein AW. Complication, adverse reaction, and insights with the use of botulinum toxin. Dermatol Surg. 2003;29:549–56.PubMedGoogle Scholar
  36. Kreyden O, Scheidegger E. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol. 2004;22:40–4.PubMedCrossRefGoogle Scholar
  37. Lakraj AAD, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins. 2013;5:821–40.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Lecouflet M, Leux C, Fenot M, Celerier P, Maillard H. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients. J Am Acad Dermatol. 2013;69(6):960–4.PubMedCrossRefGoogle Scholar
  39. Lindsay SL, Holmes S, Corbett AD, Harker M, Bovell DL. Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol. 2008;159:653–60.PubMedCrossRefGoogle Scholar
  40. Lowe NJ, Glaser DA, Eadie N, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of eficacy and safety. J Am Acad Dermatol. 2007;56(4):604–11.PubMedCrossRefGoogle Scholar
  41. Mota JJ, Sotto MN. Anatomy and histology of sweat glands. In: Almeida ART, Hexsel DM. editors. Hyperhidrosis and botulinum toxin, vol. 1. Edition of authors. São Paulo; 2004. p. 3–6.Google Scholar
  42. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. Br Med J. 2001;323(7):596–9.CrossRefGoogle Scholar
  43. Naumann M, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013;67:141–52.PubMedCrossRefGoogle Scholar
  44. Nelson L, Bachoo P, Holmes J. Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg. 2005;58:228–32.PubMedCrossRefGoogle Scholar
  45. Odderson IR. Long-term quantitative benefits of botulinum toxin A in the treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28:480–3.PubMedGoogle Scholar
  46. Rosell K, Hymnelius K, Swartling C. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol. 2013;93:335–9.PubMedCrossRefGoogle Scholar
  47. Sato K, Kang WH, Saga KT. Biology of sweat glands and their disorders I. Normal sweat gland function. J Am Acad Dermatol. 1989a;20:537–63.PubMedCrossRefGoogle Scholar
  48. Sato K, Kang WT, Saga KT. Biology of sweat glands and their disorders II. Disorders of sweat gland function. J Am Acad Dermatol. 1989b;20:713–26.PubMedCrossRefGoogle Scholar
  49. Scamoni S, Valdatta L, Frigo C, Maggiulli F, Cherubino M. Treatment of primary axillary hyperhidrosis with botulinum toxin type A: our experience in 50 patients from 2007 to 2010. ISRN Dermatol. 2012;2012:1–5.CrossRefGoogle Scholar
  50. Singh S, Davis H, Wilson P. Axillary hyperhidrosis: a review of the extent of the problem and treatment modalities. Surgeon. 2015;13(5):279–85.PubMedCrossRefGoogle Scholar
  51. Skiveren J, Larsen HN, Kjaerby E, Larsen R. The influence of needle size on pain perception in patients treated with botulinum toxin A injections for axillary hyperhidrosis. Acta Derm Venereol. 2011;91:72–4.PubMedCrossRefGoogle Scholar
  52. Strutton DR, Kowalski JW, Glaser DA, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241–8.PubMedCrossRefGoogle Scholar
  53. Talarico-Filho S, Mendonça DO, Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg. 2007;33(1):44–50.CrossRefGoogle Scholar
  54. Trindade De Almeida AR, Secco LC, Carruthers A. Handling botulinum toxins: an updated literature review. Dermatol Surg. 2011;37(11):1553–65.PubMedCrossRefGoogle Scholar
  55. Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol. 2007;156:986–9.PubMedCrossRefGoogle Scholar
  56. Wolosker N, Munia MA, Kauffman P, et al. Is gender a predictive for satisfaction among patients undergoing sympathectomy to treat palmar hyperhidrosis? Clinics. 2010;65:583–6.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ada Regina Trindade de Almeida
    • 1
    Email author
  • Suelen Montagner
    • 2
  1. 1.Department of DermatologyHospital do Servidor Público Municipal de São Paulo (SP)São PauloBrazil
  2. 2.University of São PauloCampinasBrazil

Personalised recommendations